Rift Valley Fever (RVF) is an endemic disease in Egypt causing disease in animals and humans since the 1977. Full molecular description of the national vaccine strain is a strategic concern to ensure the antigenic makeup of local vaccine is adequate to provide the required protective immunity for the vaccinated animal species and as a tool of final product quality control. Molecular characterization and phylogenetic analysis of Gc gene of M segment of RVF-ZH501 strain which used in local vaccine production in veterinary serum and vaccine research institute (VSVRI) were carried out in this study. RVF-ZH501 strain was propagated by passages on BHK cell line and then purified my plaque purification technique. RT-PCR for amplification of the Gc gene of M segment. Sequence analysis of the obtained PCR product carried out by MEGA7 program. The result of the study revealed that RVF strain ZH501 Gc genomic content has 99.5 % molecular identity to the strains firstly isolated in Egypt in 1977, so still suitable for vaccine production. ‫ـــــــــــــــــــــــــــــــــــــــــ‬
INTRODUCTION
Rift Vally Fever Virus (RVFV is the causative agent of Rift Valley fever (RVF), a zoonotic disease affecting both ruminants and humans. In ruminants, RVF is characterized by neonatal mortality and an increased incidence of abortion or foetal malformation (Ikegami, T. and Makino S. 2011) . Sheep are the species of domestic animal most susceptible to RVFV infection and newborn lambs in particular (R. Daubney; et al., 1931) . Mortality rate is significantly influenced by the age of the animal; newborn lambs are highly susceptible, with a mortality rate of greater than 90% in lambs less than a week old, associated with acute necrotic hepatitis (S.R. Gerrard, and S.T. . However, the mortality rate in adult ruminants is generally lower, at 10-30%. The abortion rate can range between 40 , 2018) . These study aims to understanding interrelationship between RVFV stoke used in vaccine production and the different isolates worldwide including wild-type ZH501 strain, for improving vaccine quality and potency.
MATERIALS AND METHODS

Virus and cells
Rift Vally Fever Virus (RVFV) strain used in the study (ZH501) was supplied by VSVRI, Cairo, Egypt. After initial passaging in suckling mice, the ZH501 strain stock was generated and titrated on BHK-21 cell line. The virus used in this study has titre of 10 8 TCID 50 / ml. MEM (Sigma, St. Louis, Mo, USA) containing 2% fetal bovine serum; FBS (Gibco BRL, Grand Island, NY, USA) are used.
Plaque assay
Selection of the different RVFV phenotypes was carried out using plaque assay as described by (Morrill JC, et al., 2010) [19] . The different developed plaques particularly those large in size, were selected, propagated in BHK-21 cells and designated RVFV ZH-501-2018.
RNA extraction
Extraction of genomic RNA using Gene JET TM RNA Purification Kit, Fermentas LIFE SCIENCES, Canada. It was done according to the manufacture's protocol.
RT-PCR and DNA sequencing
The viral RNA (5 µl) was reverse transcriptase (RT)-PCR amplified using Access quick one-step RT-PCR kit (Promega, Madison, USA). The target Gc gene of M segment was amplified using primers created on Primer3 plus software and checked in blast, RVFVF: 5'-TGTGCACACGTATCTGCAGT -3' and RVFVR: 5'-AAGAAGGCGGCATCACAAGA-3'. The optimized cycling conditions were: 1 cycle at 45ºC for 30 sec.; 1 cycle at 94ºC for 5 min; 40 cycles of (94ºC for 30 seconds, 55ºC for 30 seconds and 72ºC for 1 min), and finally 1 cycle at 72ºC for 10 min. The RT-PCR products were analyzed in 1.25% agarose gel containing 0.5 µg/ml ethidium bromide. Specific bands were excised from the gel and purified using Montáge DNA gel extraction kit (Millipore, Concord Road Billerica, MA, USA). The purified PCR product were sequenced using ABI Big-Dye 3.1 dye chemistry and ABI 3110 Prism automated DNA Genetic Analyzer (Applied Biosystems, Foster City, CA, USA).
Phylogenetic Analysis.
Nucleotide and amino acid sequences were evaluated in MEGA X software program and Phylogenetic tree based on sequences constructed by the Maximum Likelihood method of MEGA-X figure  (1) .
RESULTS
Virus plaque assay RVFZH501-2018 strain was propagated and titrated in BHK-21 cells in order to obtain large amount of concentrated virus, Virus titer increased gradually from 1 st passage (10 7.5 TCID50 / 0.1ml) 3 rd passage of (10 8 TCID50 /0.1 ml) with 0.5 log10 as mean difference, also the virus was titrated in mice by evaluating the lethal dose fifty percent (LD 50 ), and the virus titer was 10 7.4 MIPLD50 /0.2ml.
Sequence analysis of RVFV ZH-501-2018 Gc gene
Sequencing of RT-PCR product of Gc gene was conducted in both direction, and a consensus sequence of about 568 bp was used for nucleotide and deduced amino acid analysis. The sequence data was submitted to the GenBank and has obtained the accession number MH 910494. Sequence analysis of ZH-501-2018, in comparison to the reference strains (Table 1) The numbers of base differences per site sequences are shown. The analysis involved 10 nucleotide sequences. All positions containing gaps and missing data were eliminated. There were a total of 568 bp positions in the final dataset.
Protein analysis of RVFV ZH-501-2018 Gc protein
The number of amino acid differences per site from between sequences are shown. The analysis involved 10 amino acid sequences. All positions containing gaps and missing data were eliminated. There were a total of 568 positions in the final dataset. Evolutionary analyses were conducted in MEGA7 (20) (table 3) .
DISCUSSION
RVFV has demonstrated ability for emerging and reemerging in new territories after long periods of silence, the high viral titers in viraemic animals and the global changes in climate, travel and trade all makes this virus a bio threat for human and animal health (OIE, 2014). Vaccine preparation using attenuated MP12 obtained from the virulent Egyptian strain (ZH548) after random mutagenesis with 5fluorouracil mutagen (PEPIN, M.; et al., 2010) . This virus acquired mutations in all three segments and had lost its virulence when tested in mice (CAPLEN,  H.; et al., 1985) . Moreover, it was shown to induce a good immunity in ruminants after experimental inoculation (VIALAT, P.; et al., 1997).
In Egypt tissue culture passed inactivated aluminum hydroxide gel RVFV vaccines prepared from ZH501 virulent strain are commonly used (EL NIMR, M, 1980) . Molecular characterize of the vaccinal strain of RVFV to ensure adequacy of the vaccine to provide the required level of vaccinal protection and to make sure that the vaccine does not contain other than the vaccine seed virus.
Our first task was to provide evidence that vaccine strain is a homogenous mix of viruses capable of producing uniform size plaques. However, plaque assay showed only that the vaccine strain contained RVFV that produced at least two plaque sizes. The larger and more abundant of the plaques (resembled those produced by the wild-type ZH501) were picked. The smaller minute size plaques were not selected. Changes in plaque size (phenotype) have been reported for RVFV (MORRILL, J. C.; et al.,  1997) . Multiple plaque purification of the virus stock doesn't prevent the development of small size plaques (OIE , 2008) . Nucleotide sequence-based phylogenetic analysis revealed that ZH501 VSVRI are clustered with the Egyptian viruses reported in the first outbreak Fig. (1) . This is a strong indication that it is very suitable virus for vaccine production in Egypt. It will also be a very valuable tool for the identification of whether outbreaks were caused by improper inactivation of the virus during vaccine manufacture. Bovine and human RVFV strains isolated in later years from other Arabian and African countries and those used in this comparative analysis, including the Saudi_2000-10901 and Sudan 2V-2007, showed that, these strains were clustered away from the ZH501-2018. We can conclude that none of the recent outbreaks were caused by the parent virus from which the vaccine virus was isolated or ZH501-2018 itself. This means that the national Egyptian vaccine is exonerated from the most recent outbreaks in Egypt.
CONCLUSION
It is recommended that we continue to fingerprint the remaining segments of the ZH501-2018 together with circulating strains of the virus to continue to confirm that it remains the ideal vaccinal strain for current circulating RVFV strains. Finally, we can conclude that, the Egyptian strain of ZH501-2018 carries several characters make it suitable for vaccine preparation in extended period of time, its genomic make up is stable with low molecular diversity and low tolerance for mutations. ZH501-2018 is more advantageous than other strains in vaccine production.
